Education
About Us
Working with TipRanks
Follow Us
PMV Pharmaceuticals (PMVP)
NASDAQ:PMVP
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.14M | $ -1.26M | $ -650.00K | $ -1.28M | $ -318.00K |
| Operating Income | $ -85.45M | $ -80.13M | $ -77.04M | $ -58.29M | $ -34.94M |
| EBITDA | $ -73.67M | $ -67.70M | $ -72.68M | $ -56.54M | $ -34.12M |
| Net Income | $ -58.71M | $ -68.96M | $ -73.32M | $ -57.85M | $ -34.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 169.45M | $ 203.06M | $ 241.05M | $ 297.16M | $ 361.42M |
| Total Assets | $ 191.29M | $ 252.15M | $ 270.31M | $ 331.57M | $ 365.53M |
| Total Debt | $ 1.19M | $ 13.29M | $ 13.98M | $ 11.19M | $ 0.00 |
| Net Debt | $ -39.69M | $ -24.42M | $ -94.32M | $ -161.27M | $ -361.42M |
| Total Liabilities | $ 15.21M | $ 26.46M | $ 24.28M | $ 23.01M | $ 6.41M |
| Stockholders' Equity | $ 176.08M | $ 225.69M | $ 246.03M | $ 308.56M | $ 359.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -51.94M | $ -56.62M | $ -71.74M | $ -47.92M | $ -32.89M |
| Operating Cash Flow | $ -51.28M | $ -55.66M | $ -63.76M | $ -46.57M | $ -32.74M |
| Investing Cash Flow | $ 53.35M | $ -50.55M | $ -1.37M | $ -143.58M | $ 27.91M |
| Financing Cash Flow | $ 313.00K | $ 35.58M | $ 958.00K | $ 2.02M | $ 292.97M |